News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
380,387 Results
Type
Article (25878)
Company Profile (60)
Press Release (354449)
Section
Business (104242)
Career Advice (449)
Deals (16871)
Drug Delivery (50)
Drug Development (47582)
Employer Resources (47)
FDA (12255)
Job Trends (8435)
News (185880)
Policy (19407)
Tag
2024 BioCapital Digital (1)
2024 BioForest Digital (3)
2024 BioForest Standard (1)
2024 BioMidwest Digital (3)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (2)
2024 Biotech Bay Standard (6)
2024 Biotech Beach Digital (4)
2024 Biotech Beach Standard (2)
2024 Genetown Standard (2)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Digital (2)
2024 Pharm Country Standard (2)
2025 Lone Star Bio Digital (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Elite (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (1)
2026 Pharm Country Elite (1)
2026 Pharm Country Standard (1)
Academia (1744)
Accelerated approval (2)
Adcomms (8)
Allergies (68)
Alliances (26707)
ALS (52)
Alzheimer's disease (801)
Antibody-drug conjugate (ADC) (41)
Approvals (12305)
Artificial intelligence (156)
Autoimmune disease (8)
Automation (4)
Bankruptcy (142)
Best Places to Work (6893)
BIOSECURE Act (5)
Biosimilars (35)
Biotechnology (39)
Bladder cancer (44)
Brain cancer (16)
Breast cancer (172)
Cancer (1272)
Cardiovascular disease (110)
Career advice (407)
Career pathing (13)
CAR-T (64)
Cell therapy (189)
Cervical cancer (13)
Clinical research (40344)
Collaboration (411)
Compensation (113)
Complete response letters (9)
COVID-19 (1488)
CRISPR (10)
C-suite (121)
Cystic fibrosis (41)
Data (1372)
Decentralized trials (2)
Denatured (16)
Depression (28)
Diabetes (161)
Diagnostics (3500)
Digital health (10)
Diversity (5)
Diversity, equity & inclusion (13)
Drug discovery (49)
Drug pricing (53)
Drug shortages (21)
Duchenne muscular dystrophy (47)
Earnings (36736)
Editorial (19)
Employer branding (6)
Employer resources (44)
Events (51456)
Executive appointments (405)
FDA (13139)
Featured Employer (15)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (3)
Funding (377)
Gene editing (33)
Generative AI (10)
Gene therapy (120)
GLP-1 (385)
Government (3018)
Grass and pollen (3)
Guidances (35)
Healthcare (12184)
Huntington's disease (9)
IgA nephropathy (15)
Immunology and inflammation (36)
Indications (18)
Infectious disease (1553)
Inflammatory bowel disease (77)
Inflation Reduction Act (4)
Influenza (24)
Intellectual property (46)
Interviews (40)
IPO (7033)
IRA (19)
Job creations (1838)
Job search strategy (378)
Kidney cancer (7)
Labor market (8)
Layoffs (165)
Leadership (4)
Legal (3629)
Liver cancer (53)
Lung cancer (214)
Lymphoma (85)
Machine learning (2)
Management (17)
Manufacturing (93)
MASH (43)
Medical device (12855)
Medtech (12858)
Mergers & acquisitions (10107)
Metabolic disorders (397)
Multiple sclerosis (49)
NASH (11)
Neurodegenerative disease (44)
Neuropsychiatric disorders (9)
Neuroscience (1100)
NextGen: Class of 2025 (3930)
Non-profit (2820)
Northern California (1238)
Now hiring (15)
Obesity (206)
Opinion (69)
Ovarian cancer (49)
Pain (58)
Pancreatic cancer (48)
Parkinson's disease (82)
Partnered (10)
Patents (97)
Patient recruitment (71)
Peanut (37)
People (34592)
Pharmaceutical (18)
Pharmacy benefit managers (11)
Phase I (11558)
Phase II (17466)
Phase III (14354)
Pipeline (604)
Podcasts (24)
Policy (50)
Postmarket research (1668)
Preclinical (3584)
Press Release (18)
Prostate cancer (66)
Psychedelics (17)
Radiopharmaceuticals (160)
Rare diseases (171)
Real estate (2842)
Recruiting (16)
Regulatory (14127)
Reports (16)
Research institute (1605)
Resumes & cover letters (48)
Rett syndrome (2)
RNA editing (2)
RSV (18)
Schizophrenia (46)
Series A (61)
Series B (43)
Service/supplier (3)
Sickle cell disease (20)
Southern California (1085)
Special edition (3)
Spinal muscular atrophy (102)
Sponsored (12)
Startups (2119)
Stomach cancer (8)
Supply chain (34)
Tariffs (3)
The Weekly (8)
United States (11819)
Vaccines (337)
Venture capitalists (13)
Webinars (7)
Weight loss (134)
Women's health (16)
Worklife (4)
Date
Today (42)
Last 7 days (363)
Last 30 days (1443)
Last 365 days (18888)
2025 (4574)
2024 (19849)
2023 (22736)
2022 (30680)
2021 (32984)
2020 (32190)
2019 (28412)
2018 (21810)
2017 (18906)
2016 (18111)
2015 (21194)
2014 (16023)
2013 (13242)
2012 (14349)
2011 (14622)
2010 (13182)
Location
Africa (354)
Alabama (17)
Alaska (2)
Arizona (113)
Arkansas (10)
Asia (24457)
Australia (3872)
California (2796)
Canada (1142)
China (337)
Colorado (153)
Connecticut (161)
Delaware (101)
Europe (47716)
Florida (500)
Georgia (121)
Idaho (33)
Illinois (338)
India (13)
Indiana (213)
Iowa (2)
Japan (105)
Kansas (71)
Kentucky (12)
Louisiana (5)
Maine (27)
Maryland (599)
Massachusetts (1960)
Michigan (101)
Minnesota (256)
Mississippi (2)
Missouri (50)
Montana (18)
Nebraska (18)
Nevada (28)
New Hampshire (59)
New Jersey (1034)
New Mexico (9)
New York (872)
North Carolina (528)
North Dakota (3)
Northern California (1238)
Ohio (123)
Oklahoma (3)
Oregon (23)
Pennsylvania (760)
Puerto Rico (7)
Rhode Island (21)
South America (520)
South Carolina (16)
Southern California (1085)
Tennessee (72)
Texas (493)
Utah (100)
Virginia (72)
Washington D.C. (36)
Washington State (212)
West Virginia (3)
Wisconsin (37)
380,387 Results for "sirtex medical".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Sirtex Medical Appoints Matt Schmidt as New Chief Executive Officer and Board of Directors Member
Sirtex Medical announced today the appointment of Matt Schmidt as chief executive officer and board of directors member, effective March 25.
March 25, 2024
·
2 min read
Genetown
Sirtex Medical Announces Commercial Availability of New LAVA® Liquid Embolic System
Sirtex Medical (“Sirtex”), a leading manufacturer of interventional treatment solutions, announced today the commercial availability of the LAVA® Liquid Embolic System, the first and only liquid embolic approved for the treatment of peripheral vascular hemorrhage.
October 27, 2023
·
2 min read
Business
Sirtex Medical Announces Collaboration Agreement with Magle Group for EmboCept® S DSM 50 μm
Sirtex Medical (“Sirtex”) announced today the establishment of a collaboration and exclusive worldwide distribution agreement with Magle Group, a Sweden-based contract development and manufacturing organization as well as Degradable Starch Microspheres (DSM) sales and marketing company.
September 8, 2023
·
2 min read
Press Releases
Sirtex Medical Announces Certification of SIR-Spheres® Y-90 Resin Microspheres According to Medical Device Regulation (EU) 2017/745 and European Launch of the Innovative SIROS™ Delivery System
September 17, 2024
·
2 min read
Press Releases
Sirtex Medical Launches SIR-Spheres® FLEXdose SELECT Delivery Program to Enable More Selective Y-90 Treatment Plans
August 5, 2024
·
2 min read
Genetown
Sirtex Medical secures positive approval of SIR-Spheres® Y-90 resin microspheres for HCC treatment in Brazil
Sirtex Medical (“Sirtex”), a leading manufacturer of targeted liver cancer therapies, announced that the Brazilian National Agency of Supplementary Health (ANS) approved SIR-Spheres® Y-90 resin microspheres for the treatment of intermediate and advanced stage hepatocellular carcinoma (HCC) in Brazil.
September 15, 2022
·
3 min read
Press Releases
Tenon Medical(R) Receives Approval for Notice of Allowance from the European Patent Office
March 11, 2025
·
2 min read
Business
Sirtex Medical announces collaboration update with OncoSec Medical
Sirtex Medical US Holdings, Inc. (“Sirtex”), a leading manufacturer of targeted cancer therapies, announced an advancement in its strategic collaboration with OncoSec Medical, Inc. (NASDAQ: ONCS) relating to OncoSec’s lead product candidate TAVO™ (tavokinogene telseplasmid) and its electroporation (EP) gene delivery system.
January 19, 2021
·
2 min read
Press Releases
Tenon Medical(R) Announces FDA Clearance of Catamaran(R) SI Joint Fusion System for New Indication to Augment Spinal Fusion
March 24, 2025
·
2 min read
Policy
Sirtex Medical and Grand Pharmaceutical Group Limited receive NDA approval of SIR-Spheres® Y-90 resin microspheres in China from the National Medical Products Administration
Sirtex Medical, a leading manufacturer of targeted liver cancer therapies, announced with its shareholder, Grand Pharmaceutical Group Limited, that SIR-Spheres® Y-90 resin microspheres have been approved by the National Medical Products Administration for the treatment of patients with colorectal cancer liver metastases.
February 9, 2022
·
2 min read
1 of 38,039
Next
